LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer

Wang, 2017, Identification of potential serum biomarkers for breast cancer using a functional proteomics technology, Biomarker Res., 5, 11, 10.1186/s40364-017-0092-9 Wu, 2022, A micropeptide XBP1SBM encoded by lncRNA promotes angiogenesis and metastasis of TNBC via XBP1s pathway, Oncogene, 41, 2163, 10.1038/s41388-022-02229-6 Xu, 2022, LncRNA Uc003xsl.1-Mediated Activation of the NFκB/IL8 Axis Promotes Progression of Triple-Negative Breast Cancer, Cancer Res., 82, 556, 10.1158/0008-5472.CAN-21-1446 Lin, 2018, Tumor-originated exosomal lncUEGC1 as a circulating biomarker for early-stage gastric cancer, Mol. Cancer, 17, 84, 10.1186/s12943-018-0834-9 Zhou, 2020, Evaluation of C5orf66-AS1 as a Potential Biomarker for Predicting Early Gastric Cancer and Its Role in Gastric Carcinogenesis, OncoTargets and therapy, 13, 2795, 10.2147/OTT.S239965 Goldhirsch, 2013, Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013, Ann. Oncol. : Off. J. Eur. Soc. Medical Oncol., 24, 2206, 10.1093/annonc/mdt303 Deng, 2018, Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription, Oncogene, 37, 5811, 10.1038/s41388-018-0382-1 Wang, Y., Liu, X., Zhang, H., et al., 2014. Hypoxia-inducible lncRNA-AK058003 promotes gastric cancer metastasis by targeting γ-synuclein. Neoplasia (New York, N.Y.), 16(12), 1094–1106. Lee, 2003, Regulators of G1 cyclin-dependent kinases and cancers, Cancer Metastasis Rev., 22, 435, 10.1023/A:1023785332315 Engeland, 2018, Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM, Cell Death Differ., 25, 114, 10.1038/cdd.2017.172 Wu, 2020, Long noncoding RNA ZFAS1 promoting small nucleolar RNA-mediated 2'-O-methylation via NOP58 recruitment in colorectal cancer, Mol. Cancer, 19, 95, 10.1186/s12943-020-01201-w Jung, 2018, LAMB3 mediates metastatic tumor behavior in papillary thyroid cancer by regulating c-MET/Akt signals, Sci. Rep., 8, 2718, 10.1038/s41598-018-21216-0 Manda, 2000, Differential expression of the LAMB3 and LAMC2 genes between small cell and non-small cell lung carcinomas, Biochem. Biophys. Res. Commun., 275, 440, 10.1006/bbrc.2000.3331 Wang, 2013, Integrative analyses identify osteopontin, LAMB3 and ITGB1 as critical pro-metastatic genes for lung cancer, PLoS One, 8, e55714, 10.1371/journal.pone.0055714 Liang, 2018, LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein, Cell Death Differ., 25, 1980, 10.1038/s41418-018-0084-9 Ribeiro, 2018, Human Epididymis Protein 4 Promotes Events Associated with Metastatic Ovarian Cancer via Regulation of the Extracelluar Matrix, Front. Oncol., 7, 332, 10.3389/fonc.2017.00332 Wang, 2020, LAMC2 modulates the acidity of microenvironments to promote invasion and migration of pancreatic cancer cells via regulating AKT-dependent NHE1 activity, Exp. Cell Res., 391, 10.1016/j.yexcr.2020.111984 Liu, 2021, LAMC2 promotes the proliferation of cancer cells and induce infiltration of macrophages in non-small cell lung cancer, Ann. Translational Med., 9, 1392, 10.21037/atm-21-4507 Garg, 2014, Laminin-5γ-2 (LAMC2) is highly expressed in anaplastic thyroid carcinoma and is associated with tumor progression, migration, and invasion by modulating signaling of EGFR, J. Clin. Endocrinol. Metab., 99, E62, 10.1210/jc.2013-2994 Anfossi, 2018, Clinical utility of circulating non-coding RNAs - an update, Nat. Rev. Clin. Oncol., 15, 541, 10.1038/s41571-018-0035-x Zhang, 2016, Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer, Cancer Biomarkers: Section A of Disease markers, 17, 187, 10.3233/CBM-160630 Fan, 2019, Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer, J. Cell. Biochem., 120, 3185, 10.1002/jcb.27584 Tang, 2020, Long Noncoding RNA DCST1-AS1 Promotes Cell Proliferation and Metastasis in Triple-negative Breast Cancer by Forming a Positive Regulatory Loop with miR-873-5p and MYC, J. Cancer, 11, 311, 10.7150/jca.33982 Tong, 2015, Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma, Mol. Cancer, 14, 3, 10.1186/1476-4598-14-3 Arita, 2013, Circulating long non-coding RNAs in plasma of patients with gastric cancer, Anticancer Res, 33, 3185 Saliou, 2016, Circulating tumor DNA for triple-negative breast cancer diagnosis and treatment decisions, Expert Rev. Mol. Diagn., 16, 39, 10.1586/14737159.2016.1121100 Huang, 2020, Serum tRNA-derived fragments (tRFs) as potential candidates for diagnosis of nontriple negative breast cancer, J. Cell. Physiol., 235, 2809, 10.1002/jcp.29185 Wang, 2020, Serum lncRNA TINCR serve as a novel biomarker for predicting the prognosis in triple-negative breast cancer, Technol. Cancer Res. Treatment, 19, 10.1177/1533033820965574 Shin, 2015, Circulating cell-free miRNAs as biomarker for triple-negative breast cancer, Br. J. Cancer, 112, 1751, 10.1038/bjc.2015.143 Liu, 2017, A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers, Medicine, 96, e6222, 10.1097/MD.0000000000006222 Liu, 2019, LncRNA AWPPH and miRNA-21 regulates cancer cell proliferation and chemosensitivity in triple-negative breast cancer by interacting with each other, J. Cell. Biochem., 120, 14860, 10.1002/jcb.28747 Bermejo, 2019, Long intergenic noncoding RNA 299 methylation in peripheral blood is a biomarker for triple-negative breast cancer, Epigenomics, 11, 81, 10.2217/epi-2018-0121 Zhang, 2019, Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT, Mol. Cancer, 18, 40, 10.1186/s12943-019-0959-5 Ren, 2019, Knockdown of circDENND4C inhibits glycolysis, migration and invasion by up-regulating miR-200b/c in breast cancer under hypoxia, J. Experimental Clin. Cancer Res. : CR, 38, 388, 10.1186/s13046-019-1398-2 Xue, 2017, Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1, Mol. Cancer, 16, 143, 10.1186/s12943-017-0714-8 Takahashi, 2014, Modulation of hypoxia-signaling pathways by extracellular linc-RoR, J. Cell Sci., 127, 1585 Sundqvist, 2020, TGFβ and EGF signaling orchestrates the AP-1- and p63 transcriptional regulation of breast cancer invasiveness, Oncogene, 39, 4436, 10.1038/s41388-020-1299-z Cassandri, 2020, ZNF750 represses breast cancer invasion via epigenetic control of prometastatic genes, Oncogene, 39, 4331, 10.1038/s41388-020-1277-5 Sato, 2015, Clin. Exp. Metastasis, 32, 405, 10.1007/s10585-015-9705-6 Wang, 2011, Molecular mechanisms of long noncoding RNAs, Mol. Cell, 43, 904, 10.1016/j.molcel.2011.08.018 Zhang, 2020, LncRNA ANRIL acts as a modular scaffold of WDR5 and HDAC3 complexes and promotes alteration of the vascular smooth muscle cell phenotype, Cell Death Dis., 11, 435, 10.1038/s41419-020-2645-3 Sun, 2016, LncRNA GClnc1 promotes gastric carcinogenesis and may act as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern, Cancer Discov., 6, 784, 10.1158/2159-8290.CD-15-0921 Henning, 1999, Loss of laminin-5 in the epithelium-stroma interface: an immunohistochemical marker of malignancy in epithelial lesions of the breast, Histopathology, 34, 305, 10.1046/j.1365-2559.1999.00634.x Martin, K.J., Kwan, C.P., Nagasaki, K., et al., 1998. Down-regulation of laminin-5 in breast carcinoma cells. Molecular medicine (Cambridge, Mass.), 4(9), 602–613.